Important pharmacy news and late-breaking industry information updated daily.

The planned venture by Amazon.com, Berkshire Hathaway, and JPMorgan Chase to overhaul their workers’ health care follows years of similar efforts by employers to change a complex and entrenched industry, with mixed success.

Brenda Fitzgerald, MD, director of CDC, resigned Wednesday because of "complex financial interests" that repeatedly forced her to recuse herself from the agency's activities and kept her from testifying before lawmakers on public health issues. Fitzgerald said last year that she already had divested from many stock holdings.

FDA announced Tuesday a new action to combat the increasing problem of misuse and abuse of the OTC antidiarrheal drug loperamide. When used at very high and dangerous doses, the drug may be used by some individuals as a way to manage opioid withdrawal symptoms or to achieve the euphoric effects of opioid use.

No statistically significant differences found in pain reduction between treatment groups

Agency issues draft guidance for drug products labeled as homeopathic

Measure creates expanded buprenorphine prescribing

A multifaceted clinical pharmacist intervention could reduce the number of visits to the emergency department (ED) and readmissions to the hospital, according to new research. The clinical trial involved more than 1,400 Danish adults in an acute admission ward who were using five or more medications.

FDA approved on January 26 lutetium Lu 177 dotatate (Lutathera—Advanced Accelerator Applications) for the treatment of a type of cancer that affects the pancreas or gastrointestinal tract.

FDA approved on January 26 lutetium Lu 177 dotatate (Lutathera—Advanced Accelerator Applications) for the treatment of a type of cancer that affects the pancreas or gastrointestinal tract.